Centessa Pharmaceuticals PLC (CNTA)
18.19
+1.45
(+8.66%)
USD |
NASDAQ |
Nov 21, 16:00
17.10
-1.09
(-5.99%)
Pre-Market: 09:01
Centessa Pharmaceuticals Total Liabilities (Quarterly): 110.58M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 110.58M |
| June 30, 2024 | 111.88M |
| March 31, 2024 | 113.01M |
| December 31, 2023 | 124.00M |
| September 30, 2023 | 117.97M |
| June 30, 2023 | 116.32M |
| March 31, 2023 | 110.60M |
| December 31, 2022 | 108.14M |
| Date | Value |
|---|---|
| September 30, 2022 | 106.43M |
| June 30, 2022 | 101.01M |
| March 31, 2022 | 102.04M |
| December 31, 2021 | 138.08M |
| September 30, 2021 | 63.07M |
| June 30, 2021 | 58.12M |
| March 31, 2021 | 41.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
41.89M
Minimum
Mar 2021
138.08M
Maximum
Dec 2021
101.54M
Average
110.58M
Median
Sep 2024
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
| Autolus Therapeutics PLC | 350.52M |
| Mereo BioPharma Group PLC | 16.21M |
| Achilles Therapeutics PLC | 19.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.72M |
| Shareholders Equity (Quarterly) | 499.14M |